Ozkan B, Torun Y, Karakukcu C, Celik B
Children (Basel). 2024; 11(2).
PMID: 38397288
PMC: 10887301.
DOI: 10.3390/children11020176.
Shahid S, Ceglia N, Le Luduec J, McPherson A, Spitzer B, Kontopoulos T
Blood Adv. 2023; 7(17):5069-5081.
PMID: 37327118
PMC: 10471937.
DOI: 10.1182/bloodadvances.2022009468.
Mendoza-Castrejon J, Magee J
Immunol Rev. 2023; 315(1):197-215.
PMID: 36588481
PMC: 10301262.
DOI: 10.1111/imr.13180.
Lee G, Jeong S, Lee H, Oh I
Sci Rep. 2019; 9(1):1007.
PMID: 30700727
PMC: 6353913.
DOI: 10.1038/s41598-018-36999-5.
Setijono S, Kwon H, Song S
Front Oncol. 2018; 7:331.
PMID: 29441324
PMC: 5797589.
DOI: 10.3389/fonc.2017.00331.
Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to ITD mutations.
Porter S, Cluster A, Yang W, Busken K, Patel R, Ryoo J
Elife. 2016; 5.
PMID: 27879203
PMC: 5153248.
DOI: 10.7554/eLife.18882.
Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia.
Valerio D, Katsman-Kuipers J, Jansen J, Verboon L, de Haas V, Stary J
Haematologica. 2014; 99(8):e130-2.
PMID: 24816242
PMC: 4116843.
DOI: 10.3324/haematol.2013.094565.
Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in Zambia.
Slone J, Chunda-Liyoka C, Perez M, Mutalima N, Newton R, Chintu C
PLoS One. 2014; 9(2):e89102.
PMID: 24586527
PMC: 3931678.
DOI: 10.1371/journal.pone.0089102.
Cancer Stem Cells: A Moving Target.
Francipane M, Chandler J, Lagasse E
Curr Pathobiol Rep. 2013; 1(2):111-118.
PMID: 23914341
PMC: 3728091.
DOI: 10.1007/s40139-013-0010-2.
Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.
Magee J, Ikenoue T, Nakada D, Lee J, Guan K, Morrison S
Cell Stem Cell. 2012; 11(3):415-28.
PMID: 22958933
PMC: 3447536.
DOI: 10.1016/j.stem.2012.05.026.
Cancer stem cells: impact, heterogeneity, and uncertainty.
Magee J, Piskounova E, Morrison S
Cancer Cell. 2012; 21(3):283-96.
PMID: 22439924
PMC: 4504432.
DOI: 10.1016/j.ccr.2012.03.003.
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.
Balgobind B, Hollink I, Arentsen-Peters S, Zimmermann M, Harbott J, Beverloo H
Haematologica. 2011; 96(10):1478-87.
PMID: 21791472
PMC: 3186309.
DOI: 10.3324/haematol.2010.038976.
Integrating physiological regulation with stem cell and tissue homeostasis.
Nakada D, Levi B, Morrison S
Neuron. 2011; 70(4):703-18.
PMID: 21609826
PMC: 4521627.
DOI: 10.1016/j.neuron.2011.05.011.
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.
Balgobind B, van den Heuvel-Eibrink M, de Menezes R, Reinhardt D, Hollink I, Arentsen-Peters S
Haematologica. 2010; 96(2):221-30.
PMID: 20971820
PMC: 3031689.
DOI: 10.3324/haematol.2010.029660.
Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb.
Goldfarb A
J Cell Biochem. 2009; 107(3):377-82.
PMID: 19350569
PMC: 2775554.
DOI: 10.1002/jcb.22142.
Topics in pediatric leukemia--acute lymphoblastic leukemia.
Esparza S, Sakamoto K
MedGenMed. 2005; 7(1):23.
PMID: 16369328
PMC: 1681386.
Topics in pediatric leukemia--acute myeloid leukemia.
Cheng J, Sakamot K
MedGenMed. 2005; 7(1):20.
PMID: 16369325
PMC: 1681379.
Identification of a direct Dlx homeodomain target in the developing mouse forebrain and retina by optimization of chromatin immunoprecipitation.
Zhou Q, Le T, Qiu X, Spencer V, de Melo J, Du G
Nucleic Acids Res. 2004; 32(3):884-92.
PMID: 14769946
PMC: 373381.
DOI: 10.1093/nar/gkh233.
Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
Cen B, Selvaraj A, Burgess R, Hitzler J, Ma Z, Morris S
Mol Cell Biol. 2003; 23(18):6597-608.
PMID: 12944485
PMC: 193697.
DOI: 10.1128/MCB.23.18.6597-6608.2003.